你即將離開本站

並前往https://seekingalpha.com/article/4470062-vaxart-differentiated-covid-oral-route-remains-viable

Vaxart: Differentiated Covid Oral Route Remains Viable

Hence, Vaxart (NASDAQ:VXRT) with its alternative oral tablet SARS-CoV-2 ... oral cures have emerged, putting pressure on Vaxart's stock.

確定！ 回上一頁

查詢 「VXRT stock」的人也找了：

  1. VXRT stock
    2.
  2. vxrt新聞
    3.
  3. TLRY stock
    4.
  4. TSLA stock
    5.
  5. INO stock
    6.
  6. vxrt疫苗
    7.
  7. VXRT stock discussion
    8.
  8. VXRT vaccine
    9.